2-piperidone has been researched along with Neointima in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, SH; Lee, IK; Leem, J; Oh, CJ; Park, KG; Park, S | 1 |
1 other study(ies) available for 2-piperidone and Neointima
Article | Year |
---|---|
Dipeptidyl peptidase-4 inhibition by gemigliptin prevents abnormal vascular remodeling via NF-E2-related factor 2 activation.
Topics: Animals; Carotid Artery Injuries; Cell Adhesion Molecules; Cell Movement; Cell Proliferation; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; G1 Phase Cell Cycle Checkpoints; HEK293 Cells; Humans; Hyperplasia; Male; Matrix Metalloproteinase 2; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neointima; NF-E2-Related Factor 2; Piperidones; Pyrimidines; Rats, Sprague-Dawley; RNA Interference; Signal Transduction; Time Factors; Transfection; Vascular Remodeling | 2015 |